Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data

Journal of Biological Chemistry

Volumn 288, Issue 48, 2013, Pages 34555-34566

  Stavrum, Anne Kristin ^a   Heiland, Ines ^b   Schuster, Stefan ^c   Puntervoll, Pål ^d   Ziegler, Mathias ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d Uni Research AS   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMATIC CONVERSIONS; INTERMEDIATE METABOLITES; KYNURENINE PATHWAYS; METABOLIC CONTROL ANALYSIS; METABOLITE CHANGES; PHYSIOLOGICAL RANGE; TISSUE-SPECIFIC EXPRESSION; TISSUE-SPECIFIC GENE EXPRESSION;

AMINO ACIDS; BIOSYNTHESIS; DISEASES; KINETIC PARAMETERS; KINETIC THEORY; METABOLISM; METABOLITES; PHYSIOLOGY; PLANTS (BOTANY);

TISSUE;

KYNURENINE;

ARTICLE; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; KINETICS; LIVER; MATHEMATICAL MODEL; METABOLIC REGULATION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TISSUE SPECIFICITY; TRYPTOPHAN METABOLISM;

EID: 84889001380     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.474908     Document Type: Article

References (46)

1. Zádori, D., Klivényi, P., Toldi, J., Fülöp, F., and Vécsei, L. (2012) Kynurenines in Parkinson's disease. Therapeutic perspectives. J. Neural Transm. 119, 275-283
2. Kincses, Z. T., Toldi, J., and Vécsei, L. (2010) Kynurenines, neurodegeneration, and Alzheimer's disease. J. Cell Mol. Med. 14, 2045-2054
3. Campesan, S., Green, E. W., Breda, C., Sathyasaikumar, K. V., Muchowski, P. J., Schwarcz, R., Kyriacou, C. P., and Giorgini, F. (2011) The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Curr. Biol. 21, 961-966
4. Spiller, R. (2007) Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders. Alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol. Motil. 19, 25-31
5. Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., and Van den Eynde, B. J. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9, 1269-1274
6. Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., and Prendergast, G. C. (2005) Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11, 312-319
7. Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., Jugold, M., Guillemin, G. J., Miller, C. L., Lutz, C., Radlwimmer, B., Lehmann, I., von Deimling, A., Wick, W., and Platten, M. (2011) An endogenous tumourpromoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197-203
8. Munn, D. H., and Mellor, A. L. (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117, 1147-1154
9. Schwarcz, R., Bruno, J. P., Muchowski, P. J., and Wu, H.-Q. (2012) Kynurenines in the mammalian brain. When physiology meets pathology. Nat. Rev. Neurosci. 13, 465-477
10. Bender, D. A. (1983) Biochemistry of tryptophan in health and disease. Mol. Aspects Med. 6, 101-197
11. Speciale, C., Hares, K., Schwarcz, R., and Brookes, N. (1989) High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes. J. Neurosci. 9, 2066-2072
12. Salter, M., Knowles, R. G., and Pogson, C. I. (1986) Quantification of the importance of individual steps in the control of aromatic amino acid metabolism. Biochem. J. 234, 635-647
13. Kacser, H., and Burns, J. A. (1973) The control of flux. Symp. Soc. Exp. Biol. 27, 65-104
14. Heinrich, R., and Rapoport, T. A. (1974) A linear steady-state treatment of enzymatic chains. General properties, control, and effector strength. Eur. J. Biochem. 42, 89-95
15. Schuster, S., and Heinrich, R. (1996) The Regulation Of Cellular Systems, pp. 138-291, Chapman & Hall, New York
16. Vogt, A. M., Nef, H., Schaper, J., Poolman, M., Fell, D. A., Kübler, W., and Elsässer, A. (2002) Metabolic control analysis of anaerobic glycolysis in human hibernating myocardium replaces traditional concepts of flux control. FEBS Lett. 517, 245-250
17. Schuster, S., and Fell, D. (2006) Bioinformatics: From Genomes to Therapies (Lengauer, T. ed.) pp. 755-805, Wiley VCH, Weinheim
18. Fell, D. A. (1998) Increasing the flux in metabolic pathways. A metabolic control analysis perspective. Biotechnol. Bioeng. 58, 121-124
19. Heinmets, F. (1974) Computer simulation and analysis of tryptophan metabolism via kynurenine pathway in liver. Comput Biol. Med. 1, 323-336
20. Klipp, E., and Heinrich, R. (1999) Competition for enzymes in metabolic pathways. Implications for optimal distributions of enzyme concentrations and for the distribution of flux control. Biosystems 54, 1-14
21. Klipp, E., Liebermeister, W., and Wierling, C. (2004) Inferring dynamic properties of biochemical reaction networks from structural knowledge. Genome Inform. 15, 125-137
22. Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., and Smith, Q. R. (1991) Blood-brain barrier transport of kynurenines. Implications for brain synthesis and metabolism. J. Neurochem. 56, 2007-2017
23. Fujigaki, S., Saito, K., Takemura, M., Fujii, H., Wada, H., Noma, A., and Seishima, M. (1998) Species differences in L-tryptophan-kynurenine pathway metabolism. Quantification of anthranilic acid and its related enzymes. Arch. Biochem. Biophys. 358, 329-335
24. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., and Hirakawa, M. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360
25. Scheer, M., Grote, A., Chang, A., Schomburg, I., Munaretto, C., Rother, M., Söhngen, C., Stelzer, M., Thiele, J., and Schomburg, D. (2011) BRENDA, the enzyme information system in 2011. Nucleic Acids Res. 39, D670-D676
26. UniProt Consortium (2012) Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 40, D71-D75
27. Chou, T. C., and Talaly, P. (1977) A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J. Biol. Chem. 252, 6438-6442
28. Schäuble, S., Stavrum, A. K., Puntervoll, P., Schuster, S., and Heiland, I. (2013) Effect of substrate competition in kinetic models of metabolic networks. FEBS Lett. 587, 2818-2824
29. Sahle, S., Mendes, P., Hoops, S., and Kummer, U. (2008)Anew strategy for assessing sensitivities in biochemical models. Philos. Trans. A, Math. Phys. Eng. Sci. 366, 3619-3631
30. Dezso, Z., Nikolsky, Y., Sviridov, E., Shi, W., Serebriyskaya, T., Dosymbekov, D., Bugrim, A., Rakhmatulin, E., Brennan, R. J., Guryanov, A., Li, K., Blake, J., Samaha, R. R., and Nikolskaya, T. (2008) A comprehensive functional analysis of tissue specificity of human gene expression.BMCBiol. 6, 49
31. Dysvik, B., and Jonassen, I. (2001) J-Express. Exploring gene expression data using Java. Bioinformatics 17, 369-370
32. Stavrum, A. K., Petersen, K., Jonassen, I., and Dysvik, B. (2008) Analysis of gene-expression data using J-Express. Curr. Protoc. Bioinformatics doi.10.1002/0471250953.bi0703s21
33. Hoops, S., Sahle, S., Gauges, R., Lee, C., Pahle, J., Simus, N., Singhal, M., Xu, L., Mendes, P., and Kummer, U. (2006) COPASI. A COmplex PAthway SImulator. Bioinformatics 22, 3067-3074
34. Stansberg, C., Vik-Mo, A. O., Holdhus, R., Breilid, H., Srebro, B., Petersen, K., Jørgensen, H. A., Jonassen, I., and Steen, V. M. (2007) Gene expression profiles in rat brain disclose CNS signature genes and regional patterns of functional specialisation. BMC Genomics 8, 94
35. Midttun, Ø., Hustad, S., and Ueland, P. M. (2009) Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism, and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 23, 1371-1379
36. Pawlak, D., Tankiewicz, A., and Buczko, W. (2001) Kynurenine and its metabolites in the rat with experimental renal insufficiency. J. Physiol. Pharmacol. 52, 755-766
37. Chen, Y., and Guillemin, G. J. (2009) Kynurenine pathway metabolites in humans. Disease and healthy states. Int. J. Tryptophan Res. 2, 1-19
38. Carretti, N., Florio, P., Bertolin, A., Costa, C. V., Allegri, G., and Zilli, G. (2005) Serum fluctuations of total and free tryptophan levels during the menstrual cycle are related to gonadotrophins and reflect brain serotonin utilization. Hum. Reprod. 20, 1548-1553
39. Zwilling, D., Huang, S.-Y., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H.-Q., Lee, J., Truong, J., Andrews-Zwilling, Y., Hsieh, E. W., Louie, J. Y., Wu, T., Scearce-Levie, K., Patrick, C., Adame, A., Giorgini, F., Moussaoui, S., Laue, G., Rassoulpour, A., Flik, G., Huang, Y., Muchowski, J. M., Masliah, E., Schwarcz, R., and Muchowski, P. J. (2011) Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145, 863-874
40. Grzmil, M., Morin, P., Jr., Lino, M. M., Merlo, A., Frank, S., Wang, Y., Moncayo, G., and Hemmings, B. A. (2011) MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma. Cancer Res. 71, 2392-2402
41. O'Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., and Kelley, K. W. (2009) Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J. Immunol. 182, 3202-3212
42. Lee, D., Smallbone, K., Dunn, W. B., Murabito, E., Winder, C. L., Kell, D. B., Mendes, P., and Swainston, N. (2012) Improving metabolic flux predictions using absolute gene expression data. BMC Syst. Biol. 6, 73
43. Liu, Q., Yang, Q., Sun, W., Vogel, P., Heydorn, W., Yu, X.-Q., Hu, Z., Yu, W., Jonas, B., Pineda, R., Calderon-Gay, V., Germann, M., O'Neill, E., Brommage, R., Cullinan, E., Platt, K., Wilson, A., Powell, D., Sands, A., Zambrowicz, B., and Shi, Z. C. (2008) Discovery and Characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. J. Pharmacol. Exp. Ther. 325, 47-55
44. Thevandavakkam, M. A., Schwarcz, R., Muchowski, P. J., and Giorgini, F. (2010) Targeting kynurenine 3-monooxygenase (KMO). Implications for therapy in Huntington's disease. CNS Neurol. Disord. Drug Targets 9, 791-800
45. Dolusić, E., Larrieu, P., Moineaux, L., Stroobant, V., Pilotte, L., Colau, D., Pochet, L., Van den Eynde, B., Masereel, B., Wouters, J., and Frédérick, R. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(Pyridyl)ethenyl) indoles as potential anticancer immunomodulators. J. Med. Chem. 54, 5320-5334
46. Pawlak, D., Tankiewicz, A., Matys, T., and Buczko, W. (2003) Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J. Physiol. Pharmacol. 54, 175-189